Recent Articles

April 26, 2018

New Bill Calls for Transparency under 340B

Rep. Carter (R-GA-1) introduced the 340B Optimization Act on April 24, 2018 to increase transparency and ultimately improve care for low income patients. What does the 340B Optimization Act require? The 340B Optimization Act would require certain disproportionate share hospital (DSH) covered entities to annually report on their low-income utilization rate of outpatient hospital services […]

April 25, 2018

340 B Drug Pricing Scrutiny Continues

Along with following the Congressional and regulatory activity on the 340B drug pricing program, it is also important to keep abreast of recent analyses of the program in the peer-reviewed literature. The New England Journal of Medicine article, “Consequences of the 340B Drug Pricing Discount Program” examines concerns about the 340B discount program, specifically those […]

April 25, 2018

The Ongoing Debate of the 340B Drug Pricing Program

The 340B program has grown beyond its original intent and the lack of transparency about how hospitals are using their savings is of growing concern. In November 2017, CMS issued their Medicare Hospital Outpatient Prospective Payment System (OPPS) Final Rule for CY 2018 (82 FR 59216) which implemented a payment reduction for most covered outpatient […]

April 9, 2018

Highlights of CMS’ Final Rule Revising Medicare Advantage and Part D

On April 2, CMS published their final rule for contract year 2019 that revises regulations related to Medicare Advantage (MA) and the Prescription Drug Benefit Program (Part D). The primary focus of this rule is to implement provisions from the Comprehensive Addiction and Recovery Act (CARA) to help fight the opioid epidemic, implement provisions from the 21st Century Cures Act and […]

Industry Insight

Read our latest specialty pharmacy insight report here.